Idexx Laboratories
IDXX
1,058 hedge funds and large institutions have $44.5B invested in Idexx Laboratories in 2021 Q3 according to their latest regulatory filings, with 103 funds opening new positions, 338 increasing their positions, 402 reducing their positions, and 66 closing their positions.
56% more first-time investments, than exits
New positions opened: 103 | Existing positions closed: 66
3% more funds holding
Funds holding: 1,032 → 1,058 (+26)
3% less capital invested
Capital invested by funds: $46.1B → $44.5B (-$1.58B)
1.58% less ownership
Funds ownership: 85.79% → 84.2% (-1.6%)
16% less repeat investments, than reductions
Existing positions increased: 338 | Existing positions reduced: 402
21% less funds holding in top 10
Funds holding in top 10: 39 → 31 (-8)
30% less call options, than puts
Call options by funds: $205M | Put options by funds: $291M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$282M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$132M |
| 3 |
HF
HRT Financial
New York
|
+$127M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$74.1M |
| 5 |
Bank of New York Mellon
New York
|
+$73.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$765M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$177M |
| 3 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
-$135M |
| 4 |
N
Natixis
Paris,
France
|
-$99.2M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$92.5M |
IDXX Hedge Fund Activity: Q3 2021 in Review
1,058 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q3 2021, worth a combined $44.5B — down 3.4% from $46.1B a quarter earlier.
Buyers outnumbered sellers: 103 funds opened new IDXX positions and 66 closed out — a net gain of 37 holders — while 338 added to existing stakes and 402 trimmed.
The largest buyer was BlackRock, adding an estimated $282M. The largest seller was Vanguard Group, cutting an estimated $765M.
- 1,058 institutional investors held Idexx Laboratories (IDXX) as of Q3 2021, up from 1,032 in Q2 2021.
- Funds reported $44.5B of Idexx Laboratories stock for Q3 2021, down 3.4% quarter-over-quarter.
- 103 funds opened new Idexx Laboratories positions in Q3 2021 and 66 closed out, a net change of +37 holders.
- The largest Idexx Laboratories buyer in Q3 2021 was BlackRock, an estimated $282M added.
- The largest Idexx Laboratories seller in Q3 2021 was Vanguard Group, an estimated $765M sold.
Based on aggregated 13F filings for Q3 2021.